Table 3:

Factors associated with Post-Stroke Fatigue at Month 9

Predictor	Unadjusted OR (95% CI)	P-value	Adjusted OR (95% CI)	P-value
Age ≥65 years	5.83 (1.50 – 22.71)	0.01	7.02 (1.16 − 42.52)	0.03
Female gender	4.00 (1.09 − 14.71)	0.04	8.52 (1.23 − 59.16)	0.03
HDRS score at month 9 of >7	15.17(3.05–75.31)	0.0009	8.86 (1.19 − 65.88)	0.03
NIHSS score at month 9 of >4	12.50 (2.05–76.15)	0.006	5.44 (0.49 − 60.67)	0.17
Ischemic stroke	6.00 (0.70 − 51.30)	0.10	-	-
Hemorrhagic stroke (referent)	1.00
Diabetes mellitus	3.14 (0.84 − 11.72)	0.09	-	-
Body Mass Index, each unit higher	1.06 (0.95 − 1.17)	0.31
Number of antihypertensive medications	0.66 (0.33 − 1.30)	0.23	-	-
Fluoxetine use			-	-
Continuously for 9 months	1.78 (0.32 − 9.85)	0.51
Started and stopped	1.58 (0.29 − 8.62)	0.60
Started later	2.85 (0.48 − 17.10)	0.25
Never used	1.00
Interaction between Fluoxetine use at month 9 and HDRS>7	8.67 (1.37 − 54.88)	0.02